Beijing Strong Biotechnologies Inc Strategic Asset Allocation Index
Beijing Strong Biotechnologies Inc strategic asset allocation index. Beijing Strong Biotechnologies Inc (300406) has a Strategic Asset Allocation Index of 13.9% as of June 2023. Strategic assets (PP&E of CN¥481.41 Million plus long-term investments of CN¥-) total CN¥481.41 Million, measured against net assets of CN¥3.47 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Beijing Strong Biotechnologies Inc (300406) balance sheet quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Beijing Strong Biotechnologies Inc (2011–2022)
Strategic asset allocation index of Beijing Strong Biotechnologies Inc from 2011 to 2022. This chart shows how Beijing Strong Biotechnologies Inc's Strategic Asset Allocation Index has evolved across 12 annual periods from 2011 to 2022. As of June 2023, the index stands at 13.9%, representing strategic assets of CN¥481.41 Million against net assets of CN¥3.47 Billion CNY. Check Beijing Strong Biotechnologies Inc (300406) tangible net worth to evaluate the tangible quality of the company's equity base.
Beijing Strong Biotechnologies Inc Strategic Asset Allocation Index by Year (2011–2022)
Beijing Strong Biotechnologies Inc strategic asset allocation index by year from 2011 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Beijing Strong Biotechnologies Inc from 2011 to 2022, covering 12 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Beijing Strong Biotechnologies Inc market capitalisation.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 13.4% | CN¥438.93 Million | CN¥438.93 Million | CN¥- | CN¥3.27 Billion | ▲ +0.9 pp |
| 2021 | 12.6% | CN¥366.19 Million | CN¥366.19 Million | CN¥- | CN¥2.91 Billion | ▲ +3.1 pp |
| 2020 | 9.5% | CN¥323.56 Million | CN¥323.56 Million | CN¥- | CN¥3.42 Billion | ▼ -4.4 pp |
| 2019 | 13.8% | CN¥272.64 Million | CN¥272.64 Million | CN¥- | CN¥1.97 Billion | ▼ -2.8 pp |
| 2018 | 16.7% | CN¥283.93 Million | CN¥233.93 Million | CN¥50.00 Million | CN¥1.70 Billion | ▲ +4.8 pp |
| 2017 | 11.8% | CN¥181.01 Million | CN¥181.01 Million | CN¥- | CN¥1.53 Billion | ▲ +0.2 pp |
| 2016 | 11.6% | CN¥161.01 Million | CN¥161.01 Million | CN¥- | CN¥1.39 Billion | ▲ +3.4 pp |
| 2015 | 8.2% | CN¥96.00 Million | CN¥96.00 Million | CN¥- | CN¥1.18 Billion | ▲ +1.1 pp |
| 2014 | 7.1% | CN¥69.94 Million | CN¥69.94 Million | CN¥- | CN¥987.03 Million | ▼ -9.3 pp |
| 2013 | 16.4% | CN¥77.96 Million | CN¥77.96 Million | CN¥- | CN¥476.31 Million | ▼ -3.3 pp |
| 2012 | 19.7% | CN¥75.91 Million | CN¥75.91 Million | CN¥- | CN¥385.67 Million | ▼ -1.8 pp |
| 2011 | 21.5% | CN¥61.96 Million | CN¥61.96 Million | CN¥- | CN¥288.66 Million | — |